Intrinsic O
connectivity O
patterns O
of O
task-defined O
brain O
networks O
allow O
individual O
prediction O
of O
cognitive O
symptom O
dimension O
of O
schizophrenia O
and O
are O
linked O
to O
molecular O
architecture O
Background O
: O
Despite O
the O
marked O
inter-individual O
variability O
in O
the O
clinical O
presentation O
of O
schizophrenia O
, O
it O
remains O
unclear O
the O
extent O
to O
which O
individual O
dimensions O
of O
psychopathology O
relate O
to O
the O
functional O
variability O
in O
brain O
networks O
among O
patients O
. O

Here O
, O
we O
address O
this O
question O
using O
network-based O
predictive O
modeling O
of O
individual O
psychopathology O
along O
four O
data-driven O
symptom O
dimensions O
. O

Follow-up O
analyses O
assess O
the O
molecular O
underpinnings O
of O
predictive O
networks O
by O
relating O
them O
to O
neurotransmitter-receptor O
distribution O
patterns O
. O

Methods O
: O
We O
investigated O
resting-state O
fMRI O
data O
from O
147 O
schizophrenia O
patients O
recruited O
at O
seven O
sites O
. O

Individual O
expression O
along O
negative O
, O
positive O
, O
affective O
, O
and O
cognitive O
symptom O
dimensions O
was O
predicted O
using O
relevance O
vector O
machine O
based O
on O
functional O
connectivity O
within O
17 O
meta-analytic O
task-networks O
following O
a O
repeated O
10-fold O
cross-validation O
and O
leave-one-site-out O
analyses O
. O

Results O
were O
validated O
in O
an O
independent O
sample O
. O

Networks O
robustly O
predicting O
individual O
symptom O
dimensions O
were O
spatially O
correlated O
with O
density O
maps O
of O
nine O
receptors/transporters O
from O
prior O
molecular O
imaging O
in O
healthy O
populations O
. O

Results O
: O
Ten-fold O
and O
leave-one-site-out O
analyses O
revealed O
five O
predictive O
network-symptom O
associations O
. O

Connectivity O
within O
theory-of-mind O
, O
cognitive O
reappraisal O
, O
and O
mirror O
neuron O
networks O
predicted O
negative O
, O
positive O
, O
and O
affective O
symptom O
dimensions O
, O
respectively O
. O

Cognitive O
dimension O
was O
predicted O
by O
theory-of-mind O
and O
socio-affective-default O
networks O
. O

Importantly O
, O
these O
predictions O
generalized O
to O
the O
independent O
sample O
. O

Intriguingly O
, O
these O
two O
networks O
were O
positively O
associated O
with O
D1 O
dopamine O
receptor O
and O
serotonin O
reuptake O
transporter O
densities O
as O
well O
as O
dopamine-synthesis-capacity O
. O

Conclusions O
: O
We O
revealed O
a O
robust O
association O
between O
intrinsic O
functional O
connectivity O
within O
networks O
for O
socio-affective O
processes O
and O
the O
cognitive O
dimension O
of O
psychopathology O
. O

By O
investigating O
the O
molecular O
architecture O
, O
this O
work O
links O
dopaminergic O
and O
serotonergic O
systems O
with O
the O
functional O
topography O
of O
brain O
networks O
underlying O
cognitive O
symptoms O
in O
schizophrenia O
. O

Materials O
and O
Methods O
Sample O
A O
total O
of O
147 O
schizophrenia O
patients O
from O
seven O
centers O
located O
in O
Europe O
and O
the O
USA O
represented O
the O
main O
sample O
( O
Table O
S1 O
; O
Supplement O
) O
. O

These O
sites O
differed O
significantly O
in O
illness O
duration O
( O
p O
< O
0.001 O
) O
( O
Table O
S1 O
) O
. O

An O
independent O
sample O
with O
117 O
schizophrenia O
patients O
( O
Table O
S2 O
; O
Supplement O
) O
retrieved O
from O
the O
Bipolar-Schizophrenia O
Network O
on O
Intermediate O
Phenotypes O
( O
B-SNIP O
) O
database O
was O
used O
for O
independent O
model O
validation O
. O

For O
both O
samples O
, O
diagnosis O
of O
schizophrenia O
was O
established O
based O
on O
the O
DSM-IV O
, O
the O
DSM-IV-TR O
, O
or O
the O
ICD-10 O
criteria O
( O
see O
Supplement O
and O
[ O
6 O
] O
) O
. O

These O
international O
datasets O
cover O
a O
broad O
range O
of O
clinical O
states O
, O
settings O
, O
and O
medical O
systems O
, O
facilitating O
identification O
of O
robust O
network-symptom O
associations O
. O

Current O
drug O
dosages O
of O
antipsychotic O
medication O
were O
olanzapine-equivalent O
transformed O
. O

For O
each O
site O
, O
subjects O
gave O
written O
informed O
consent O
and O
study O
approval O
was O
given O
by O
the O
respective O
ethics O
committees/institutional O
review O
boards O
. O

Approval O
for O
pooled O
re-analysis O
was O
provided O
by O
the O
ethics O
committee O
of O
the O
University O
of O
Düsseldorf O
, O
Germany O
. O

Calculation O
of O
dimensional O
symptom O
scores O
Severity O
of O
psychopathology O
was O
assessed O
using O
the O
PANSS O
. O

The O
30 O
PANSS O
items O
were O
compressed O
into O
four O
( O
negative O
, O
positive O
, O
affective O
, O
and O
cognitive O
) O
symptom O
dimensions O
( O
Figure O
S1A O
) O
identified O
in O
our O
prior O
factorization O
analysis O
on O
two O
large O
, O
multi-site O
schizophrenia O
samples O
as O
stable O
and O
well-generalizable O
across O
populations O
, O
settings O
, O
and O
medical O
systems O
. O

Each O
dimensional O
score O
for O
an O
individual O
was O
calculated O
as O
the O
dot O
product O
between O
the O
coefficients O
loaded O
on O
the O
particular O
dimension O
within O
the O
dimensional-structure O
( O
Figure O
S1 O
) O
and O
the O
30 O
PANSS O
item O
scores O
of O
that O
individual O
( O
as O
implemented O
in O
DCTS O
: O
http O
: O
//webtools.inm7.de/sczDCTS/ O
) O
. O

Higher O
scores O
on O
a O
dimension O
indicate O
more-severe O
symptoms O
( O
Figure O
S1B O
) O
. O

Definition O
of O
functional O
brain O
networks O
Seventeen O
functional O
networks O
, O
which O
cover O
a O
broad O
range O
of O
domains O
reflecting O
cognitive O
, O
socio-affective O
, O
and O
sensory-motor O
functions O
that O
have O
been O
implicated O
in O
schizophrenia O
, O
were O
employed O
( O
Table O
S3 O
) O
. O

These O
networks O
were O
based O
on O
coordinate-based O
meta-analyses O
and O
represent O
regions O
demonstrating O
convergent O
activations O
associated O
with O
specific O
functional O
domains O
across O
many O
prior O
task-fMRI O
studies O
. O

They O
hence O
provide O
the O
best O
“ O
a O
priori O
” O
estimate O
of O
the O
location O
of O
specific O
functional O
networks O
and O
hence O
here O
assessed O
by O
resting-state O
fMRI O
in O
new O
subjects O
. O

For O
convenience O
, O
we O
grouped O
these O
17 O
networks O
into O
six O
broad O
functional O
domains O
( O
Figure O
1 O
& O
Table O
S3 O
) O
, O
though O
it O
must O
be O
stressed O
that O
each O
network O
was O
analyzed O
separately O
. O

FMRI O
data O
processing O
All O
resting-state O
fMRI O
scans O
( O
Tables O
S4 O
& O
S5 O
) O
were O
preprocessed O
using O
SPM12 O
( O
http O
: O
//www.fil.ion.ucl.ac.uk/spm O
) O
( O
see O
[ O
6 O
] O
and O
Supplement O
) O
. O

After O
excluding O
subjects O
with O
excessive O
head-motion O
or O
poor O
image O
quality O
( O
cf O
. O

Supplement O
) O
, O
126 O
and O
100 O
schizophrenia O
patients O
were O
retained O
in O
the O
main O
and O
the O
B-SNIP O
validation O
sample O
, O
respectively O
( O
Table O
1 O
) O
. O

Head O
motion O
differed O
significantly O
between O
the O
sites O
but O
did O
not O
correlate O
with O
the O
residuals O
of O
any O
symptom O
dimensions O
after O
adjusting O
for O
age/gender/site O
. O

Still O
, O
we O
adjusted O
head-motion O
effects O
in O
predictive O
modeling O
as O
a O
conservative O
approach O
to O
rule O
out O
( O
any O
) O
possible O
predictability O
based O
on O
movement O
. O

White O
matter O
and O
CSF O
signals O
as O
well O
as O
24 O
head-motion O
parameters O
were O
regressed O
out O
from O
the O
overall O
fMRI O
time-series O
but O
the O
global O
mean O
signals O
were O
not O
removed O
given O
ongoing O
controversies O
. O

Voxels O
within O
a O
6 O
mm O
sphere O
around O
each O
of O
the O
meta-analytically O
derived O
peak-activation O
coordinate O
formed O
a O
node O
. O

The O
first O
eigenvariate O
of O
the O
time-series O
from O
all O
the O
voxels O
within O
each O
node O
was O
calculated O
as O
the O
regional O
characteristic O
time-series O
containing O
better O
signal-to-noise O
ratio O
than O
the O
peak O
voxel O
alone O
. O

For O
each O
network O
, O
Pearson O
’ O
s O
correlation O
was O
calculated O
between O
the O
characteristic O
time-series O
for O
each O
pair O
of O
the O
nodes O
resulting O
in O
an O
N O
x O
N O
matrix O
of O
resting-state O
functional O
connectivity O
( O
rs-FC O
) O
. O

The O
upper O
triangle O
of O
the O
resulting O
connectivity O
matrix O
was O
extracted O
, O
linearized O
and O
Fisher O
’ O
s O
Z-transformed O
to O
provide O
the O
features O
for O
our O
predictive O
modeling O
. O

Prediction O
of O
symptom O
dimensions O
using O
network O
rs-FC O
Multivariable O
regression O
via O
a O
relevance O
vector O
machine O
( O
RVM O
) O
was O
implemented O
and O
evaluated O
using O
500x O
repeated10-fold O
cross-validation O
, O
individually O
for O
each O
combination O
of O
functional O
network O
and O
symptom O
dimension O
in O
the O
main O
sample O
. O

Using O
each O
network O
individually O
in O
the O
model O
was O
intended O
to O
ensure O
the O
functional O
specificity O
of O
our O
results O
. O

Importantly O
, O
RVM O
is O
a O
sparse O
learning O
method O
, O
i.e. O
, O
only O
a O
few O
of O
the O
learned O
feature O
weights O
are O
non-zero O
, O
lending O
interpretability O
as O
to O
which O
features O
( O
connections O
) O
are O
predictive O
. O

As O
recommended O
, O
the O
symptom O
dimensional-scores O
and O
rs-FC O
features O
were O
adjusted O
for O
confounding O
effects O
of O
age O
, O
gender O
, O
site O
, O
and O
head-motion O
( O
DVARS O
) O
. O

To O
avoid O
data-leakage O
within O
cross-validation O
, O
confound O
regression O
models O
were O
learned O
only O
on O
the O
training-set O
and O
then O
applied O
on O
both O
training O
and O
test O
data O
. O

The O
RVM O
model O
trained O
on O
the O
( O
confound-adjusted O
) O
training O
data O
and O
was O
then O
applied O
to O
the O
( O
confound-adjusted O
) O
held-out O
data O
. O

Folds O
were O
stratified O
to O
accommodate O
different O
sample O
sizes O
across O
sites O
. O

Prediction O
performance O
was O
evaluated O
using O
Pearson O
’ O
s O
correlation O
between O
the O
( O
adjusted O
) O
scores O
and O
their O
predictions O
. O

Significant O
predictions O
were O
further O
validated O
for O
their O
generalizability O
across O
sites O
using O
leave-one-site-out O
cross-validation O
following O
the O
same O
schematic O
but O
training O
on O
all O
sites O
but O
one O
and O
testing O
on O
the O
left-out O
site O
( O
Supplement O
) O
. O

Statistical O
significance O
of O
the O
cross-validation-based O
correlations O
was O
determined O
through O
1000 O
permutations O
by O
shuffling O
the O
symptom O
dimensional-scores O
( O
lowest O
p=0.001 O
, O
right-tailed O
; O
Supplement O
) O
. O

Critically O
, O
we O
validated O
predictive O
associations O
confirmed O
by O
leave-one-site-out O
cross-validation O
in O
the O
independent O
B-SNIP O
sample O
. O

For O
this O
, O
we O
trained O
RVM O
models O
on O
the O
significantly O
predictive O
networks O
in O
the O
entire O
main O
sample O
and O
then O
, O
without O
further O
fitting O
or O
modification O
, O
applied O
them O
to O
held-out O
B-SNIP O
data O
. O

Robust O
associations O
passing O
this O
strict O
three-step O
validation O
procedure O
were O
then O
further O
assessed O
as O
described O
below O
. O

In O
addition O
, O
connections O
within O
the O
networks O
identified O
with O
robust O
associations O
with O
symptoms O
were O
combined O
to O
test O
the O
possible O
improvement O
in O
prediction O
performance O
. O

Control O
analyses O
were O
performed O
by O
repeating O
all O
validation O
procedures O
by O
including O
illness O
duration O
or O
olanzapine-equivalent O
dosage O
as O
confounds O
. O

For O
comparison O
, O
i O
) O
we O
predicted O
the O
three O
PANSS O
subscales O
( O
positive O
, O
negative O
, O
and O
general O
psychopathology O
) O
using O
the O
same O
three-step O
validation O
procedure O
and O
each O
network O
individually O
as O
in O
our O
main O
analyses O
, O
and O
ii O
) O
we O
predicted O
the O
four O
symptom O
dimensions O
using O
whole-connectome O
( O
39060 O
connections O
) O
which O
comprised O
pairwise O
connectivity O
between O
all O
the O
nodes O
pooled O
from O
the O
17 O
meta-analytic O
networks O
. O

Identification O
of O
reliably O
predictive O
connections O
and O
subnetworks O
The O
intrinsic O
feature O
selection O
in O
RVM O
through O
its O
sparse O
modeling O
was O
leveraged O
to O
identify O
reliably O
predictive O
connections O
and O
the O
potential O
subnetworks O
formed O
by O
them O
. O

A O
connection O
was O
identified O
as O
reliably O
predictive O
when O
it O
had O
non-zero O
weights O
in O
: O
i O
) O
at O
least O
80 O
% O
of O
the O
10-fold O
cross-validation O
repetitions O
, O
ii O
) O
at O
least O
six O
out O
of O
the O
seven O
( O
i.e. O
, O
> O
80 O
% O
) O
leave-one-site-out O
analyses O
, O
and O
iii O
) O
the O
models O
trained O
on O
the O
entire O
main O
sample O
for O
validation O
in O
B-SNIP O
. O

The O
cutoff O
of O
80 O
% O
is O
suggested O
as O
a O
conservative O
threshold O
in O
both O
real O
and O
simulated O
data O
. O

To O
assess O
the O
predictive O
capacity O
of O
the O
subnetworks O
, O
RVM O
models O
were O
trained O
using O
the O
rs-FC O
of O
the O
subnetworks O
on O
the O
main O
sample O
and O
tested O
in O
B-SNIP O
. O

Spatial O
correlation O
with O
receptor/transporter O
densities O
Finally O
, O
we O
evaluated O
the O
topographical O
relationship O
between O
network-node O
location O
and O
the O
distribution O
of O
several O
receptor/transporter O
systems O
, O
assessing O
for O
highly-expressed O
receptors/transporters O
in O
the O
identified O
networks O
relative O
to O
the O
entire O
brain O
. O

This O
was O
tested O
by O
comparing O
the O
average O
receptor/transporter O
density O
across O
all O
nodes O
within O
a O
given O
network O
against O
a O
null-distribution O
based O
on O
1000 O
random O
network O
configurations O
generated O
by O
re-distributing O
the O
nodes O
throughout O
the O
grey O
matter O
while O
preserving O
the O
between-node O
distances O
( O
±6mm O
tolerance O
) O
. O

Seven O
dopamine O
and O
serotonin O
receptors O
( O
dopaminergic O
: O
D1 O
and O
D2/3 O
; O
serotonergic O
: O
5-HT1a O
, O
5-HT1b O
, O
and O
5-HT2a O
) O
and O
transporters O
( O
dopamine O
transporter O
and O
5-HTT O
serotonin O
reuptake O
transporter O
) O
, O
together O
with O
F-DOPA O
( O
a O
reflection O
of O
presynaptic O
dopamine-synthesis-capacity O
) O
and O
the O
GABAergic O
receptor O
GABAa O
were O
investigated O
. O

While O
all O
systems O
are O
linked O
to O
schizophrenia O
, O
we O
here O
tested O
specific O
receptors/transporters O
. O

Density O
estimates O
were O
derived O
from O
average O
group O
maps O
of O
healthy O
volunteers O
( O
D1 O
: O
N=13 O
; O
D2/3 O
: O
N=7 O
; O
5-HT1a O
: O
N=35 O
; O
5-HT1b O
: O
N=23 O
; O
5-HT2a O
: O
N=19 O
; O
5-HTT O
: O
N=18 O
; O
dopamine O
transporter O
: O
N=147 O
; O
F-DOPA O
: O
N=12 O
; O
GABAa O
: O
N=6 O
) O
scanned O
in O
prior O
multi-tracer O
molecular O
imaging O
studies O
( O
Supplement O
) O
. O

For O
comparability O
, O
these O
maps O
, O
in O
MNI152 O
space O
, O
were O
all O
resampled O
to O
an O
isotropic O
2mm O
spatial O
resolution O
as O
in O
our O
fMRI O
data O
and O
linearly O
rescaled O
to O
0-100 O
. O

Furthermore O
, O
the O
significantly O
higher O
expressed O
receptors/transporters O
were O
entered O
into O
a O
spatial O
correlation O
analysis O
calculated O
as O
rank O
correlation O
between O
the O
node O
importance O
scores O
and O
receptor/transporter O
densities O
calculated O
for O
these O
nodes O
( O
Figure O
4B O
) O
. O

The O
node O
importance O
score O
was O
calculated O
by O
summing O
the O
selection O
frequency O
of O
the O
connections O
of O
each O
node O
derived O
from O
the O
repeated O
10-fold O
cross-validation O
. O

Bootstrap O
analysis O
was O
conducted O
to O
ensure O
robustness O
. O

To O
establish O
the O
statistical O
significance O
of O
a O
spatial O
correlation O
against O
chance O
, O
spatial O
permutation O
test O
was O
employed O
where O
the O
null O
distribution O
was O
estimated O
based O
on O
the O
correlations O
between O
the O
node O
importance O
scores O
for O
a O
given O
network O
and O
the O
nodal O
receptor/transporter O
densities O
extracted O
from1000 O
simulated O
( O
random O
) O
networks O
( O
Supplement O
) O
. O

